Dr. Vose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
986840 Nebraska Medical Center
Buffett Cancer Center
Omaha, NE 68198Phone+1 402-559-5600Fax+1 402-559-4835- Is this information wrong?
Summary
- Dr. Julie Vose is an oncologist in Omaha, NE and is affiliated with multiple hospitals in the area, including Nebraska Medicine - Bellevue and Nebraska Medicine - Nebraska Medical Center. She received her medical degree from University of Nebraska College of Medicine and has been in practice 33 years. She specializes in hematologic oncology and specializes in non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia, stem cell transplantation, and CAR-T cell therapy.
Education & Training
- University of ColoradoMBA, Health Administration, 2009 - 2011
- University of Colorado Business SchoolM.B.A., Health Administration, 2009 - 2011
- University of Nebraska Medical Center College of MedicineFellowship, Hematology and Medical Oncology, 1988 - 1990
- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1984 - 1988
- University of Nebraska College of MedicineClass of 1984
- University of Nebraska Medical CenterB.S., with Distinction, 1978 - 1979
Certifications & Licensure
- IA State Medical License 1986 - 2025
- NE State Medical License 1984 - 2024
- CA State Medical License 1998 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors for Cancer Castle Connolly, 2005-2015
- America's Top Doctors Castle Connolly, 2009-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- Combination Chemotherapy With or Without Rituximab in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma Start of enrollment: 1999 Sep 01
- Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma Start of enrollment: 2000 May 01
- Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma Start of enrollment: 1999 Jun 25
- Join now to see all
Publications & Presentations
PubMed
- MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications.Chengfeng Bi, Yuhua Huang, Roshia Ali, Fang Wang, Xia Yang, Alyssa Bouska, Lu Xu, Xinbao Hao, Javeed Iqbal, Dennis D Weisenburger, Matthew A Lunning, Wing C Chan, Juli...> ;Haematologica. 2024 Mar 28
- 3 citationsBridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium.Michael D Jain, Miriam T Jacobs, Feng Gao, Loretta J Nastoupil, Jay Y Spiegel, Yi Lin, Saurabh Dahiya, Matthew Lunning, Lazaros Lekakis, Patrick Reagan, Olalekan Oluwo...> ;Blood Advances. 2024 Feb 27
- Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma.Gerson, J., Handorf, E., Villa, D., Gerrie, A., Chapani, P., Li, S., Medeiros, L., Wang, M., Cohen, J., Churnetski, M., Hill, B., Sawalha, Y., Hernandez-Ilizaliturri, ...> ;Blood Advances. 2023 Dec 26
- Join now to see all
Journal Articles
- Angioimmunoblastic T-cell lymphoma managementMosalpuria K, Bociek RG, Vose JM, Semin Hematol, 1/1/2014
- A multicenter study of primary breast diffuse large B-cell lymphoma in the rituximab eraHosein PJ, Maragulia JC, Salzburg MP, Press OW, Habermann TM, Vose JM, Bast M, Advani RH, Tibshirahni R, Evens AM, Islam N, Leonard JP, Martin P, Zelenetz Ad, Lossos IS, Br J Haematol, 1/1/2014
- Phase I/II study of Velcade BEAM (V-BEAM) and autologous hematopoietic stem cell transplantation (ASCT) for relapsed indolent non-Hodgkin lymphoma (NHL), transformed o...William BM, Allen MS, Loberiza FR, Bociek RG, Bierman PJ, Armitage JO, Vose JM, Biol Blood Marrow Trans, 1/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Characteristics and Outcomes of Patients Who Did Not Develop CRS after Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma: Results from the US Lymph...Julie M Vose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma _ Single Institution ExperienceJulie M Vose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- PRISM: A Platform Protocol for the Treatment of Relapsed/Refractory Aggressive Non-Hodgkin LymphomaJulie M Vose, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Lectures
- American Board of Internal Medicine/ASCO Medical Oncology Learning and Assessment: The New...ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019
- CAR T-Cell Therapy in Lymphoma, Myeloma, and Leukemia _ Clinical Updates and Innovations61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Axicabtagene Ciloleucel (Axi-cel) CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma: Real World ExperienceClinically Re...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Ibrutinib No Longer Approved for MCL, MZL: How This Change Will Affect PatientsApril 28th, 2023
- VA Manchester Healthcare Names Associate DirectorDecember 16th, 2020
- Lymphoma Research Foundation to Host Nationwide Virtual RallyApril 28th, 2020
- Join now to see all
Grant Support
- Flt-Pet/Ct For Therapy Monitoring Of DlbclNational Cancer Institute2011–2012
- Nebraska/Kansas Blood And Marrow Transplant Research NetworkNational Heart, Lung, And Blood Institute2011
- Nebraska Blood And Marrow Transplant Research NetworkNational Heart, Lung, And Blood Institute2001–2010
- Core--Tissue ProcurementNational Cancer Institute1996–1999
- Transplantation For Nhl--Comparison Of Psct And ABMTNational Cancer Institute1993–1996
Professional Memberships
- Fellow
Hospital Affiliations
- Nebraska Medicine - Nebraska Medical CenterOmaha, Nebraska
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: